HF
BCTX

HRT Financial’s Briacell Therapeutics BCTX Stock Holding History

HRT Financial’s Portfolio BCTX Stock Details BCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Buy
+34,904
New +$129K ﹤0.01% 3577
2025
Q1 		– Sell
-253
Closed -$21K – 2532
2024
Q4 		$21K Sell
253
-242
-49% -$29K ﹤0.01% 2197
2024
Q3 		$92K Buy
+495
New +$55.6K ﹤0.01% 2057

Other funds holding BCTX

CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
LCM
LuminArx Capital Management New York $224M AUM
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

HRT Financial's BCTX Position: Q2 2026 in Review

HRT Financial opened a new position in Briacell Therapeutics (BCTX) in Q2 2026: 34,904 shares worth $113K. The stake represents ﹤0.01% of the portfolio and ranks #3577 among its holdings. This is a return to the name: HRT Financial previously reported a position in BCTX as recently as Q4 2024.

HRT Financial first reported a position in BCTX in Q3 2024 and has held it in 3 quarters since. 19 funds tracked by Wall St. Rank hold BCTX as of Q2 2026.

  • HRT Financial held 34,904 shares of Briacell Therapeutics worth $113K as of Q2 2026.
  • Briacell Therapeutics was a new HRT Financial position in Q2 2026.
  • Briacell Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3577 holding.
  • HRT Financial first reported a position in Briacell Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • 19 funds tracked by Wall St. Rank held Briacell Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.